| Type |
Details |
Score |
| Strain |
| Attribute String: |
mutant strain, coisogenic, targeted mutation |
|
•
•
•
•
•
|
| Allele |
| Name: |
late endosomal/lysosomal adaptor, MAPK and MTOR activator 5; targeted mutation 1e, Helmholtz Zentrum Muenchen GmbH |
| Allele Type: |
Targeted |
| Attribute String: |
Null/knockout, Reporter |
|
•
•
•
•
•
|
| Allele |
| Name: |
late endosomal/lysosomal adaptor, MAPK and MTOR activator 4; targeted mutation 1e, Wellcome Trust Sanger Institute |
| Allele Type: |
Targeted |
| Attribute String: |
Null/knockout, Reporter |
|
•
•
•
•
•
|
| Allele |
| Name: |
late endosomal/lysosomal adaptor, MAPK and MTOR activator 2; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH |
| Allele Type: |
Targeted |
| Attribute String: |
Conditional ready, Null/knockout, Reporter |
|
•
•
•
•
•
|
| Allele |
| Name: |
late endosomal/lysosomal adaptor, MAPK and MTOR activator 5; targeted mutation 1b, Helmholtz Zentrum Muenchen GmbH |
| Allele Type: |
Targeted |
| Attribute String: |
Null/knockout, Reporter |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, targeted mutation |
|
•
•
•
•
•
|
| Allele |
| Name: |
late endosomal/lysosomal adaptor, MAPK and MTOR activator 1; targeted mutation 1b, Wellcome Trust Sanger Institute |
| Allele Type: |
Targeted |
| Attribute String: |
Null/knockout, Reporter |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, targeted mutation |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, targeted mutation |
|
•
•
•
•
•
|
| Allele |
| Name: |
late endosomal/lysosomal adaptor, MAPK and MTOR activator 4; endonuclease-mediated mutation 1, Institute of Molecular Genetics |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, targeted mutation |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, mutant strain, endonuclease-mediated mutation |
|
•
•
•
•
•
|
| Allele |
| Name: |
late endosomal/lysosomal adaptor, MAPK and MTOR activator 3; endonuclease-mediated mutation 1, Helmholtz Zentrum Muenchen GmbH |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, mutant strain, endonuclease-mediated mutation |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, mutant strain, endonuclease-mediated mutation |
|
•
•
•
•
•
|
| Allele |
| Name: |
late endosomal/lysosomal adaptor, MAPK and MTOR activator 5; endonuclease-mediated mutation 1, Shanghai Model Organisms Center |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, mutant strain, endonuclease-mediated mutation |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
| Allele |
| Name: |
late endosomal/lysosomal adaptor, MAPK and MTOR activator 3; endonuclease-mediated mutation 1, Shanghai Model Organisms Center |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, mutant strain, endonuclease-mediated mutation |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Lamtor2/Lamtor2 |
| Background: |
involves: 129P2/OlaHsd * C57BL/6 * SJL |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Mlst8/Mlst8 |
| Background: |
involves: 129S5/SvEvBrd |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Lamtor1/Lamtor1 |
| Background: |
involves: C57BL/6 |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Lamtor5/Lamtor5 |
| Background: |
Not Specified |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Lamtor1/Lamtor1 |
| Background: |
C57BL/6N-Lamtor1/Tcp |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Lamtor3/Lamtor3 |
| Background: |
C57BL/6NCrl-Lamtor3/Ieg |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Lamtor4/Lamtor4 |
| Background: |
C57BL/6N-Lamtor4/Ccpcz |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Lamtor5/Lamtor5 |
| Background: |
C57BL/6N-Lamtor5/Bay |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Meak7/Meak7 |
| Background: |
C57BL/6NCrl-Meak7/Tcp |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Lamtor5/Lamtor5 |
| Background: |
involves: C57BL/6 |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Sancak Y |
| Year: |
2010 |
| Journal: |
Cell |
| Title: |
Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. |
| Volume: |
141 |
| Issue: |
2 |
| Pages: |
290-303 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Jacinto E |
| Year: |
2006 |
| Journal: |
Cell |
| Title: |
SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. |
| Volume: |
127 |
| Issue: |
1 |
| Pages: |
125-37 |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
238
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
154
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
145
 |
| Fragment?: |
true |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Wang L |
| Year: |
2009 |
| Journal: |
J Biol Chem |
| Title: |
Mammalian target of rapamycin complex 1 (mTORC1) activity is associated with phosphorylation of raptor by mTOR. |
| Volume: |
284 |
| Issue: |
22 |
| Pages: |
14693-7 |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Lamtor2/Lamtor2 Tg(KRT5-cre)1Tak/? |
| Background: |
involves: 129P2/OlaHsd * C3H * C57BL/6 * SJL |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Lamtor5/Lamtor5 Tg(Ins2-cre)25Mgn/? |
| Background: |
involves: C57BL/6 * DBA |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Lamtor2/Lamtor2 Tg(Alb1-cre)7Gsc/? |
| Background: |
involves: 129P2/OlaHsd * C57BL/6 * FVB/N |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Zhang CS |
| Year: |
2022 |
| Journal: |
Nat Metab |
| Title: |
The aldolase inhibitor aldometanib mimics glucose starvation to activate lysosomal AMPK. |
| Volume: |
4 |
| Issue: |
10 |
| Pages: |
1369-1401 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Xiong Y |
| Year: |
2014 |
| Journal: |
Autophagy |
| Title: |
ARG2 impairs endothelial autophagy through regulation of MTOR and PRKAA/AMPK signaling in advanced atherosclerosis. |
| Volume: |
10 |
| Issue: |
12 |
| Pages: |
2223-38 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Minami K |
| Year: |
2007 |
| Journal: |
J Virol |
| Title: |
Suppression of viral replication by stress-inducible GADD34 protein via the mammalian serine/threonine protein kinase mTOR pathway. |
| Volume: |
81 |
| Issue: |
20 |
| Pages: |
11106-15 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Pearce LR |
| Year: |
2007 |
| Journal: |
Biochem J |
| Title: |
Identification of Protor as a novel Rictor-binding component of mTOR complex-2. |
| Volume: |
405 |
| Issue: |
3 |
| Pages: |
513-22 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
MacMillan D |
| Year: |
2005 |
| Journal: |
J Cell Sci |
| Title: |
In smooth muscle, FK506-binding protein modulates IP3 receptor-evoked Ca2+ release by mTOR and calcineurin. |
| Volume: |
118 |
| Issue: |
Pt 23 |
| Pages: |
5443-51 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Aeder SE |
| Year: |
2004 |
| Journal: |
Oncogene |
| Title: |
PKC-eta mediates glioblastoma cell proliferation through the Akt and mTOR signaling pathways. |
| Volume: |
23 |
| Issue: |
56 |
| Pages: |
9062-9 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Sparks CA |
| Year: |
2010 |
| Journal: |
Oncogene |
| Title: |
Targeting mTOR: prospects for mTOR complex 2 inhibitors in cancer therapy. |
| Volume: |
29 |
| Issue: |
26 |
| Pages: |
3733-44 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Inoki K |
| Year: |
2003 |
| Journal: |
Genes Dev |
| Title: |
Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. |
| Volume: |
17 |
| Issue: |
15 |
| Pages: |
1829-34 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Tee AR |
| Year: |
2005 |
| Journal: |
FEBS Lett |
| Title: |
Analysis of mTOR signaling by the small G-proteins, Rheb and RhebL1. |
| Volume: |
579 |
| Issue: |
21 |
| Pages: |
4763-8 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
David-Morrison G |
| Year: |
2016 |
| Journal: |
Dev Cell |
| Title: |
WAC Regulates mTOR Activity by Acting as an Adaptor for the TTT and Pontin/Reptin Complexes. |
| Volume: |
36 |
| Issue: |
2 |
| Pages: |
139-51 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Miyazaki M |
| Year: |
2009 |
| Journal: |
Am J Physiol Cell Physiol |
| Title: |
REDD2 is enriched in skeletal muscle and inhibits mTOR signaling in response to leucine and stretch. |
| Volume: |
296 |
| Issue: |
3 |
| Pages: |
C583-92 |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, targeted mutation, mutant strain |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Bhartur SG |
| Year: |
2000 |
| Journal: |
Biochem Biophys Res Commun |
| Title: |
Genomic structure of murine Rab11 family members. |
| Volume: |
269 |
| Issue: |
2 |
| Pages: |
611-7 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Cui X |
| Year: |
2020 |
| Journal: |
Biochim Biophys Acta Gen Subj |
| Title: |
Heat shock factor 4 regulates lysosome activity by modulating the αB-crystallin-ATP6V1A-mTOR complex in ocular lens. |
| Volume: |
1864 |
| Issue: |
3 |
| Pages: |
129496 |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
mutant stock, targeted mutation |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
mutant strain, coisogenic, targeted mutation |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
mutant strain, coisogenic, targeted mutation |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Lamtor2/Lamtor2 Meox2/Meox2<+> |
| Background: |
involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Lamtor1/Lamtor1<+> |
| Background: |
C57BL/6N-Lamtor1/Tcp |
| Zygosity: |
ht |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Lamtor3/Lamtor3<+> |
| Background: |
C57BL/6NCrl-Lamtor3/Ieg |
| Zygosity: |
ht |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Lamtor4/Lamtor4<+> |
| Background: |
C57BL/6N-Lamtor4/Ccpcz |
| Zygosity: |
ht |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Lamtor5/Lamtor5<+> |
| Background: |
C57BL/6N-Lamtor5/Bay |
| Zygosity: |
ht |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Lamtor5/Lamtor5<+> |
| Background: |
involves: C57BL/6 |
| Zygosity: |
ht |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Choi KC |
| Year: |
2010 |
| Journal: |
J Neurochem |
| Title: |
A novel mTOR activating protein protects dopamine neurons against oxidative stress by repressing autophagy related cell death. |
| Volume: |
112 |
| Issue: |
2 |
| Pages: |
366-76 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Matthew EM |
| Year: |
2009 |
| Journal: |
Cell Cycle |
| Title: |
The p53 target Plk2 interacts with TSC proteins impacting mTOR signaling, tumor growth and chemosensitivity under hypoxic conditions. |
| Volume: |
8 |
| Issue: |
24 |
| Pages: |
4168-75 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Hong-Brown LQ |
| Year: |
2006 |
| Journal: |
Alcohol Clin Exp Res |
| Title: |
Alcohol and indinavir adversely affect protein synthesis and phosphorylation of MAPK and mTOR signaling pathways in C2C12 myocytes. |
| Volume: |
30 |
| Issue: |
8 |
| Pages: |
1297-307 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Hong-Brown LQ |
| Year: |
2010 |
| Journal: |
J Cell Biochem |
| Title: |
Alcohol and PRAS40 knockdown decrease mTOR activity and protein synthesis via AMPK signaling and changes in mTORC1 interaction. |
| Volume: |
109 |
| Issue: |
6 |
| Pages: |
1172-84 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Hashimoto Y |
| Year: |
2018 |
| Journal: |
Genes Cells |
| Title: |
TMEM55B contributes to lysosomal homeostasis and amino acid-induced mTORC1 activation. |
| Volume: |
23 |
| Issue: |
6 |
| Pages: |
418-434 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Boggiatto PM |
| Year: |
2014 |
| Journal: |
Microbes Infect |
| Title: |
Targeted extracellular signal-regulated kinase activation mediated by Leishmania amazonensis requires MP1 scaffold. |
| Volume: |
16 |
| Issue: |
4 |
| Pages: |
328-36 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Qin Y |
| Year: |
2010 |
| Journal: |
Nat Genet |
| Title: |
Germline mutations in TMEM127 confer susceptibility to pheochromocytoma. |
| Volume: |
42 |
| Issue: |
3 |
| Pages: |
229-33 |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Domain |
| Description: |
Transmembrane protein 127 (TMEM127) modulates mTOR function in the endolysosome. Its interaction with early endosomal GTPase Rab5 to inhibit mTOR signalling seems to be related with its tumour-suppressing properties [, ]. This entry represents the transmembrane region of this protein and similar animal sequences. |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
117
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
436
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Waters S |
| Year: |
2009 |
| Journal: |
FEBS Lett |
| Title: |
Interactions with LC3 and polyubiquitin chains link nbr1 to autophagic protein turnover. |
| Volume: |
583 |
| Issue: |
12 |
| Pages: |
1846-52 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Julien LA |
| Year: |
2010 |
| Journal: |
Mol Cell Biol |
| Title: |
mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling. |
| Volume: |
30 |
| Issue: |
4 |
| Pages: |
908-21 |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Dai DF |
| Year: |
2019 |
| Journal: |
Geroscience |
| Title: |
Differential effects of various genetic mouse models of the mechanistic target of rapamycin complex I inhibition on heart failure. |
| Volume: |
41 |
| Issue: |
6 |
| Pages: |
847-860 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Schiefermeier N |
| Year: |
2014 |
| Journal: |
J Cell Biol |
| Title: |
The late endosomal p14-MP1 (LAMTOR2/3) complex regulates focal adhesion dynamics during cell migration. |
| Volume: |
205 |
| Issue: |
4 |
| Pages: |
525-40 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Stanfel MN |
| Year: |
2009 |
| Journal: |
Biochim Biophys Acta |
| Title: |
The TOR pathway comes of age. |
| Volume: |
1790 |
| Issue: |
10 |
| Pages: |
1067-74 |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Domain |
| Description: |
DEP domain-containing mTOR-interacting protein (DEPTOR) is an mTOR inhibitor that plays pivotal roles in the pathogenesis and progression of many tumours [, ].This entry represents the first DEP domain of DEPTOR. Its function is not clear. |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Domain |
| Description: |
DEP domain-containing mTOR-interacting protein (DEPTOR) is an mTOR inhibitor that plays pivotal roles in the pathogenesis and progression of many tumours [, ].This entry represents the second DEP domain of DEPTOR. Its function is not clear. |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Family |
| Description: |
Ragulator complex protein LAMTOR3 (for lysosomal adaptor and MAPK and MTOR activator 3) is a regulator of the TOR pathway, which is a signalling cascade that promotes cell growth in response to growth factors, energy levels, and amino acids []. |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Shen K |
| Year: |
2016 |
| Journal: |
Cell Rep |
| Title: |
The Rag-Ragulator Complex Regulates Lysosome Function and Phagocytic Flux in Microglia. |
| Volume: |
14 |
| Issue: |
3 |
| Pages: |
547-559 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Hu B |
| Year: |
2017 |
| Journal: |
Onco Targets Ther |
| Title: |
Downregulation of DEPTOR inhibits the proliferation, migration, and survival of osteosarcoma through PI3K/Akt/mTOR pathway. |
| Volume: |
10 |
|
| Pages: |
4379-4391 |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Family |
| Description: |
Lamtor4 is a component of the Ragulator complex, a complex that functions as a guanine nucleotide exchange factor for the Rag GTPases that signal amino acid levels to mTORC1. The mTOR Complex 1 (mTORC1) pathway regulates cell growth in response to numerous cues. Lamtor4 is required for mTORC1 activation by amino acids []. The Rag-Ragulator complex also has functions independent of mTOR signaling; RagA and Lamtor4 are essential regulators of lysosomes in microglia []. |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion, Atsu Aiba |
| Allele Type: |
Transgenic |
| Attribute String: |
Constitutively active, Inducible, Inserted expressed sequence |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion, Atsu Aiba |
| Allele Type: |
Transgenic |
| Attribute String: |
Constitutively active, Inserted expressed sequence |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion 2969, Albert La Spada |
| Allele Type: |
Transgenic |
| Attribute String: |
Conditional ready, Humanized sequence, Inserted expressed sequence, Reporter |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
congenic, mutant strain, transgenic |
|
•
•
•
•
•
|
| Allele |
| Name: |
gene trap ROSA 26, Philippe Soriano; transgene insertion 1, Ernesto Bernal-Mizrachi |
| Allele Type: |
Targeted |
| Attribute String: |
Inducible, Inserted expressed sequence, Reporter |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Mtor/Mtor Cnp/Cnp<+> |
| Background: |
involves: 129S4/SvJae * C57BL/6 |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Messina V |
| Year: |
2010 |
| Journal: |
Biol Reprod |
| Title: |
Differential contribution of the MTOR and MNK pathways to the regulation of mRNA translation in meiotic and postmeiotic mouse male germ cells. |
| Volume: |
83 |
| Issue: |
4 |
| Pages: |
607-15 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Cardenas-Rodriguez M |
| Year: |
2013 |
| Journal: |
Hum Mol Genet |
| Title: |
The Bardet-Biedl syndrome-related protein CCDC28B modulates mTORC2 function and interacts with SIN1 to control cilia length independently of the mTOR complex. |
| Volume: |
22 |
| Issue: |
20 |
| Pages: |
4031-42 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Finelli MJ |
| Year: |
2016 |
| Journal: |
J Biol Chem |
| Title: |
The Evolutionarily Conserved Tre2/Bub2/Cdc16 (TBC), Lysin Motif (LysM), Domain Catalytic (TLDc) Domain Is Neuroprotective against Oxidative Stress. |
| Volume: |
291 |
| Issue: |
6 |
| Pages: |
2751-63 |
|
•
•
•
•
•
|